Title Tag Does Medicaid Cover Ozempic? 2026 State-by-State Guide

Coverage questions for Medicaid don't always have a single, universal answer and the answer to the question of "Ozempic" is no exception. You are more likely to have your prescription approved based on your diagnosis, and less likely based on your state.

Yes, Medicaid pays for Ozempic in every state in the USA for Type 2 Diabetes, as state programs have to cover the drugs if they're FDA-approved and from a manufacturer part of the federal rebate program. In terms of weight loss, the situation is mixed; while there is no state that currently covers GLP-1 for weight management, there is only about 13 states that cover any GLP-1 for obesity, as per KFF. Most states will need a prior authorization, proof of diabetes diagnosis and sometimes a trial of metformin first.

More states may start to relax limits as the new federal price for state Medicaid programs could make that more realistic, so 2026 will be a year to closely watch.

Medicaid Coverage for Type 2 Diabetes: The National Rule

All state Medicaid programs will cover the cost of Ozempic if it is prescribed for the treatment of type 2 diabetes. Novo Nordisk participates in the federal Medicaid Drug Rebate Program, which mandates the coverage of FDA-approved medications by states for manufacturers that have to pay rebates. This translates into the diabetes indication being guaranteed across the country.

It's the gatekeeping that changes. Most states have prior authorization criteria including a documented type 2 diabetes diagnosis, a recent A1C, and often step therapy, including metformin or a first-line drug. Some states only allow for 1 pen per month or have the requirement of renewing every 6-12 months. This paperwork is done by your prescriber's office, but it is helpful to know your state's criteria to push this along.

Does Any State Cover Ozempic for Weight Loss?

As of yet, no state reimburses the cost of taking Ozempic to lose weight, since it hasn't been approved for the purpose. Wegovy is the weight-loss approved version of the drug and a different product. If you are interested in asking about Medicaid and weight loss, it is important to find out if your state will even pay for these anti-obesity GLP-1s.

As of the most recent AMCP federal policy update, about 13 state Medicaid programs cover GLP-1s for obesity treatment, including states like California, Pennsylvania, Michigan, and Wisconsin, each with its own BMI thresholds and program requirements. Under the federal pricing agreement in November of 2025, the price for the $245 monthly coverage was extended to state Medicaid programs, which policy analysts hoped would give further impetus to states to include obesity services in the 2026 and 2027 budget cycles.

In order to lose weight with Medicaid coverage, make sure that your state offers coverage for Wegovy or Zepbound, not Ozempic, and read our state-specific guides at the end of this article.

What Does Ozempic Cost on Medicaid?

Covered Diabetes Prescriptions, Medicaid is the costliest insurance in America. Federal regulations place a limit on the amount of copay you have to pay, usually $0 to $8 per prescription (based on your state and income). Some states do not require any payments for preferred diabetes medications.

The state, meanwhile, now pays far less than it used to. The $245 negotiated price announced in November 2025, reported by Axios, replaced effective costs that often exceeded $700 per month even after standard Medicaid rebates. Lower state costs reduce the budget pressure that drove restrictive prior authorization rules in many programs.

How to Get Ozempic Approved Through Your State Medicaid Program

First, check to see if your diagnosis is eligible, as there is a checklist of what is considered valid. If you have type 2 diabetes, Medicare will pay for Ozempic, but your medical record must show you have the condition and include any recent lab tests. Ask your GP or prescriber to do this, as some states have a different GLP-1 that they prefer, and they will need to try that first.

After waiting until the prior authorization has expired, resume the medication. Most states have a response time of 24 to 72 hours. If you are denied, you have a right to a fair hearing, and re-submissions with full documentation often are successful. The appeal may also be handled by community health centers or a member services representative for Medicaid managed care.

During a redetermination period, if you fall into a gap and are no longer eligible for Medicaid, Novo Nordisk's patient assistance program provides free medication to those who qualify for low income.